|
|
Introduction |
Plasma fractions are special medicines
that are produced by using the
high technology and know-how to
clean/separate a variety of protein
components from the plasma. Starting
from the nation's first Albumin
in 1971, Green Cross currently
manufactures more than 12 plasma
fractions including the Immunoglobulin,
Antihemophilic Factor, Antithrombin
and Tetanus Immunoglobulin, which
have become a background of Green
Cross' worldwide competitiveness
in this field. Green Cross is
also utilizing the genetic engineering
to develop the second generation
plasma fractions as well as promoting
the strategic alliance with the
advanced companies overseas to
become a globalized pharmaceutical
company.
|
|
|
